Term ends Sep 12, 2031 · Medium confidence
20-year base term ends Sep 12, 2031
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 8,895,245), so the cap could be lower.
Sep 12, 2011
Sep 12, 2031
Apr 8, 2014
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 12, 2011, when application 13/230,703, the earliest non-provisional in its chain, was filed (this one was filed Jul 23, 2013) | Sep 12, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,895,245) | resolves to Sep 12, 2031, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 12, 2031 | Medium confidence |
This family
| US 8,895,245 | In force no later than Nov 2031 | no later than Nov 2031 |
| US 9,175,331 | In force May 2029 | May 2029 |
| Application PCT/US2013/030565 | PCT application no patent term | no patent term |
| US 8,691,507 | this patent Sep 2031 | Sep 2031 |
| US 9,334,527 | In force May 2029 | May 2029 |
| US 9,333,217 | In force May 2029 | May 2029 |
| US 9,949,999 | In force May 2029 | May 2029 |
| Application 15/132,610 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 20, 2013 Reel 31251, frame 486 | Copeland, Robert A.; Richon, Victoria M.; Scott, Margaret D.; Sneeringer, Christopher J.; Kuntz, Kevin W.; Knutson, Sarah K.; Pollock, Roy M. | Epizyme, Inc. | Assignment of Assignor's Interest |
| Nov 19, 2019 Reel 51057, frame 848 | Epizyme, Inc. | Biopharma Credit PLC | Security Interest |
| Aug 13, 2022 Reel 61165, frame 501 | Biopharma Credit PLC | Epizyme, Inc. | Termination and Release of Security Interest in Patents at Reel/Frame: 051057/0848 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,895,245, ends no earlier than this term, so it caps nothing.